Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study have?
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study has 288 citations in the OpenAlex counts ScholarIQ stores.
When was Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study published?
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study has 2005 year in the ScholarIQ index.
What is the open-access status of Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study?
Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study has green oa status in the ScholarIQ index.
What is the DOI of Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study?
The DOI for Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study is on the source record.
What is the PMID of Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study?
The PMID for Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study is on the source record.
What is the OpenAlex record for Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study?
The OpenAlex for Long-term hydroxyurea therapy for infants with sickle cell anemia: the HUSOFT extension study is on the source record.